The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by University of Colorado, Denver.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Omni Bio Pharmaceutical, Inc.
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01319331
First received: March 17, 2011
Last updated: January 7, 2013
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2013
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
No publications provided by University of Colorado, Denver

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):